PGM5: a novel diagnostic and prognostic biomarker for liver cancer

BACKGROUND: Liver cancer is a common malignancy and a significant public health problem worldwide, but diagnosis and prognostic evaluation remain challenging for clinicians. Metabolic reprogramming is a hallmark of cancer, and we therefore examined the diagnostic and prognostic value of a metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Yan, Li, Yanqing, Jiang, Peiqiang, Han, Wei, Liu, Yahui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568247/
https://www.ncbi.nlm.nih.gov/pubmed/31218127
http://dx.doi.org/10.7717/peerj.7070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568247/
https://www.ncbi.nlm.nih.gov/pubmed/31218127
http://dx.doi.org/10.7717/peerj.7070

Ejemplares similares